ABSTRACT
BACKGROUND
Traumatic brain injury (TBI) is a leading cause of death and disability, with around 7⋅7 million people living with TBI-related disabilities in the European Union (Stocchetti et al., 2015) . Severity is diagnosed using radiological criteria (Bersten et al., 2014) along with the Glasgow coma scale (GCS), with a GCS of 3-8 signifying severe injury (Maas et al., 2008) . In severe TBI, the primary injury (diffuse damage and contusions) can lead to the development of a secondary injury (cerebral oedema and/or haematomas) (Bersten et al., 2014) . TBI management primarily focuses on maintaining adequate cerebral blood flow (CBF), controlling intracranial pressure (ICP) <20 mmHg and reduction of neuronal metabolic requirements through the use of, for example, sedation (Brain Trauma Foundation, American Association of Neurological Surgeons (AANS), Congress of Neurological Surgeons (CNS), AANS/CNS Joint Section on Neurotrauma and Critical Care, 2007) .
Therapeutic hypothermia (TH) is the induced cooling of patients to 32-35 ∘ C and is proposed to ameliorate the mechanisms of secondary brain injury, improving neurological outcome by decreasing free radical production, preserving the blood-brain barrier (BBB), attenuating ionic disruption and inhibiting excitatory amino-acid release. This inhibits the formation of cerebral oedema and lowers ICP (Busto et al., 1989; Smith and Hall, 1996) . Three studies in the early 1990s documented that TH lowered ICP and improved neurological outcome compared to normothermic patients (Clifton et al., 1993; Marion et al., 1993; Shiozaki et al., 1993) . However, a subsequent study by Clifton et al. (2001) found that TH did not lead to improved neurological outcome. Further studies reported limited success and have failed to provide statistically significant evidence advocating its use (Chen et al., 2001; Shiozaki et al., 2001 Shiozaki et al., , 2003 . Refractory intracranial hypertension (IH) during re-warming of patients has been noted, suggesting that TH delays the pathological processes of brain injury rather than preventing injury. However, the trend towards improved neurological outcomes means TH remains an area of research, with guidelines suggesting that TH for more than 48 h may reduce mortality (Brain Trauma Foundation, American Association of Neurological Surgeons (AANS), Congress of Neurological Surgeons (CNS), AANS/CNS Joint Section on Neurotrauma and Critical Care, 2007) .
AIM AND OBJECTIVES
The aim of this review is to appraise recent research examining the effects of TH in patients with TBI to answer the question in adults with a severe TBI, does the use of TH compared with normothermia affect neurological outcome? Secondary objectives are: 
METHODOLOGY Search strategy
A comprehensive search of the PubMed, MEDLINE, CINAHL and Cochrane Library databases was undertaken to identify peer-reviewed primary research investigating the effects of TH in adult patients with TBI. The following search terms, which incorporated MeSH terms, were used: 'cool*' OR 'hypotherm*' OR 'temperature management' AND 'traumatic brain injury' OR 'TBI' OR 'head injury' OR 'IH' OR 'ICP'. The reference lists of selected studies were also manually searched as were the contents of relevant journals.
Selection criteria
During the selection process, the following inclusion criterion was applied: articles published in English, primary research, involve adult patients, investigate the effectiveness of induced hypothermia for traumatic brain injury and published since 2004. Articles were excluded if they considered TH following stroke, spontaneous intracerebral bleeds, hepatic encephalopathy or cardiac arrest. In addition, studies investigating different methods of inducing hypothermia, measuring ICP, cerebral perfusion or blood flow were excluded.
Quality assessment
Identified literature was screened for relevance using a three-stage process ensuring a systematic approach. Firstly, the title was reviewed, and following this, the abstract was reviewed to ensure the inclusion/exclusion criteria were adhered to. The third stage of screening involved reviewing the studies in full to ensure all fulfilled the search criteria. Both authors undertook the review process independently and then agreed on the eligibility of the studies for inclusion.
Data extraction and appraisal
The two authors extracted the data, such as methodology, sample sizes and statistics (mean scores, standard deviation, p values), from each included study using a standardized extraction form. Outcomes for neurological outcome at different time points were extracted as well as other data recorded during the study (such as ICP). The eligible studies were appraised using either the critical appraisal skills programme (CASP) randomized controlled trial (RCT) checklist or the CASP cohort study checklist depending on research methodology/design.
Findings

Search outcome
The initial electronic search yielded 122 results (excluding duplicates) once inclusion/exclusion criteria were applied ( Figure 1 ). The hand search identified 2 further studies, resulting in a total of 124 studies. During the screening process, studies were removed as follows: firstly, 75 studies were excluded as within the title, they investigated different monitoring methods, hypothermia generally or involved liver failure/cardiac arrest situations. Secondly, following abstract review, a further 20 studies were excluded as they did not adhere to the inclusion/exclusion criteria. The remaining 29 studies were read in full, and 21 were excluded as they did not match the inclusion/exclusion criteria of primary research and involving TBI. Therefore, eight studies were identified via the search process. The eight identified studies involved 689 patients and consisted of six RCTs, two of which were multi-centred, and two quasi-experimental studies involving retrospective comparisons against historical control data (Table 1) . Six studies compared the effectiveness of TH against the use of normothermia; one compared the effectiveness of long-term (5 days) TH against short-term (2 days) TH; and a further study compared the effectiveness of TH maintained at 35 ∘ C as opposed to 33 ∘ C. Inclusion and exclusion criteria varied between the studies as well as the methods of inducing and managing TH. Following critical appraisal, four common themes emerged:
1. Influence on neurological outcome. 2. Influence on ICP. 3. Correlation between neurological outcome and brain pathology. 4. Complications.
Influence on neurological outcome
As with previous reviews, it was found that the influence on neurological outcome of TH is conflicting, with some studies showing a benefit and others not; this may be due to variations in study design and when outcomes were measured. All eight studies measured neurological outcome using the Glasgow outcome score (GOS) (Jennet and Bond, 1975) , although at varying periods after initial injury (6 months to 2 years). All studies considered a score of ≥4 as a favourable outcome and a score ≤3 as an unfavourable outcome. Three studies concluded that TH improves neurological outcome with statistical significance (Smrčka et al., 2005; Inamasu et al., 2006; Lee et al., 2010) . Lee et al. (2010) reported a favourable outcome in 71⋅4% of patients managed with TH in conjunction with P ti O 2 (brain tissue oxygenation)-guided management of cerebral perfusion pressure (CPP), 60% in the TH group without P ti O 2 -guided management and 50% in the normothermia group (p = 0⋅04). However, the use of three treatment strategies makes it difficult to distinguish whether the improved outcomes were because of the guided CPP management or TH, and the sample size is limited. Inamasu et al. (2006) also reported a higher rate of favourable outcome in patients treated with TH compared to normothermia; 27⋅8% of patients treated with TH had a favourable outcome, with a survival rate of 33⋅3% compared to 6⋅7% of patients in the normothermia group (p < 0⋅05). However, the study design and sample size offers questionable reliability. Smrčka et al. (2005) likewise reported a statistically significant increase in GOS score in the TH group compared to the normothermia group (p = 0⋅01); however, there are gaps in the reporting of TH protocols, such as re-warming rates, and their defined physiological goals, such as ICP and CPP, which may differ from the other studies. In contrast, three studies concluded that there is no statistically significant evidence that TH improves overall neurological outcome in patients with TBI (Qiu et al., 2005; Qiu et al., 2007; Clifton et al., 2011) ; however, a higher rate of favourable outcome in the TH groups was found. Clifton et al. (2011) reported no statistical difference in the rate of poor outcome between the TH group and normothermia group (60 and 56%, respectively, p = 0⋅67), and no difference was observed in mortality rates between the two groups (23 and 18%, respectively, p = 0⋅52). However inconsistency in the treatment between both groups in regards to evacuation of haematomas may have influenced the findings and creates a bias in this RCT. Clifton et al. (2011) reported that 33% of the patients in the TH group had craniotomies compared to 46% in the normothermia group, which may have influenced the incidence of rebound IH and affected the neurological outcome between the two groups. Qiu et al. (2005) reported that 53⋅5% had a favourable outcome in the TH group compared to 27⋅9% in the normothermia group (p < 0⋅05), indicating that TH was effective at improving neurological outcome; however, there are some inconsistencies in the study design and a small sample size. Qiu et al. (2007) reported similar figures. However, despite the statistical significance, neurological outcome was assessed at different times (ranging 6 months to 2 years in all studies); therefore, patients had a substantially longer time to recover compared to others, which would influence results. Jiang et al. (2006) and Tokutomi et al. (2009) evaluated the influence duration and temperature of TH has on neurological outcome respectively. Jiang et al. (2006) reported that long-term (5 days) TH improved the rate of favourable neurological outcome compared to short-term (2 days) TH (43⋅5% versus 29%, p < 0⋅05), suggesting that longer periods of cooling are more efficacious. This was a multi-centred RCT with a reasonable sample size, so these results have a greater reliability than other studies. Tokutomi et al. (2009) reported weak evidence that the mortality rate was lower in the 35 ∘ C group (p = 0⋅08), suggesting that the milder temperature caused lower risk to the patients. However, this study used historical data as the control, which leads to questionable reliability of these findings.
Influence on ICP
All the studies reviewed monitored ICP, with five reporting that TH significantly lowered ICP during TH compared to treatment with normothermia (Qiu et al., 2005; Smrčka et al., 2005; Inamasu et al., 2006; Qiu et al., 2007; Lee et al., 2010) . However, only Lee et al. (2010) demonstrated a sustained decrease in ICP levels following re-warming; this was the only study to titrate re-warming in relation to rebound IH and opted to re-induce hypothermia when ICP values increased. Jiang et al. (2006) found that ICP significantly rebounded after re-warming in the short-term TH group and was significantly higher thereafter compared to the long-term TH group (p < 0⋅05). Tokutomi et al. (2009) found that TH maintained at 35 ∘ C and 33 ∘ C both controlled ICP under 20 mmHg, with no significant differences in the incidence of IH; however, ICP did rebound above 20 mmHg in both groups 8 days after injury. Clifton et al. (2011) reported the only adverse effect on ICP, with a significantly higher incidence of IH compared to the normothermia group (71% versus 60%, p = 0⋅003).
These findings suggest that TH does help to reduce ICP, but this does not consistently have a lasting effect. If rebound IH occurs 
Correlation between neurological outcome and brain pathology
Three studies investigated the correlation between brain pathology and neurological outcome, finding that patients with a haematoma and treated with TH had better neurological outcomes than patients with primary brain injury only (Smrčka et al., 2005; Inamasu et al., 2006; Clifton et al., 2011) . Clifton et al. (2011) reported a higher rate of favourable outcome in patients treated with TH and surgical removal of intracranial haematomas compared to patients with diffuse brain injury (p = 0⋅01). Further analysis identified that patients treated with surgical removal of haematomas had better outcomes when treated with TH instead of normothermia (p = 0⋅02), and patients with diffuse injury had poorer outcomes in the TH group compared to the normothermia group (p = 0⋅09) and a higher mortality rate (p = 0⋅08) (Clifton et al., 2011) . Furthermore, IH was more common in patients with diffuse brain injury and treated with TH compared to normothermia (p = 0⋅003), suggesting that TH is not as effective with diffuse brain injury. Both Inamasu et al. (2006) and Smrčka et al. (2005) found that patients with haematoma-type injuries had better outcomes and survival rates compared to patients with contusions when treated with TH compared to normothermia (p < 0⋅05). Their findings suggest that patients with contusions do not benefit from treatment with TH. These studies, although limited, suggest that TH is more effective with haematomas; when considering other reviews, this suggestion is not explicit.
Complications
There are potential complications of TH; however, five of the studies concluded that TH was not associated with severe complications (Qiu et al., 2005; Smrčka et al., 2005; Qiu et al., 2007; Lee et al., 2010; Clifton et al., 2011) . Pulmonary infection was the complication with the highest incidence in the studies, with the exception of Clifton et al. (2011) who reported a significantly higher rate of overall complications, such as IH and infection in the TH group (408 episodes versus 208, p = 0⋅01); however, this was influenced by the high incidence of IH in the TH group, whilst infectious, cardiovascular and bleeding complications showed no significant difference. Qiu et al. (2005) observed a higher incidence of pulmonary infection in the TH groups compared to the normothermia groups (60⋅5% versus 39⋅5%, p < 0⋅05), with similar findings by Qiu et al. (2007) (57⋅5% versus 32⋅5%, p = 0⋅025). Additionally, Tokutomi et al. (2009) found evidence that patients cooled at a lower temperature (33 ∘ C compared to 35 ∘ C) were more susceptible to pneumonia (p = 0⋅09); however, this was not statistically significant.
Three studies noted an increase in coagulopathies in patients treated with TH. Qiu et al. (2005) and Qiu et al. (2007) observed thrombocytopenia in 62⋅8% and 57⋅5%, respectively, of patients treated with TH. Clifton et al. (2011) noted decreases in partial thromboplastin times (PTT) (p = 0⋅004), although these were slight, and there was no significant difference in bleeding complications between the TH and normothermia groups.
Serum potassium level abnormalities in the TH groups were noted in two studies. Clifton et al. (2011) reported minor but significant decreases in mean serum potassium levels in the TH group (3⋅6 versus 3⋅8 mmol/L, p = 0⋅0005). Tokutomi et al. (2009) also reported decreases in serum potassium levels in patients cooled to 33 ∘ C compared to 35 ∘ C, most significantly on day 5 post-injury (3⋅7 versus 4⋅0 mmol/L respectively, p = 0⋅005). Interestingly, both studies cooled their patients to 33 ∘ C, whilst others used milder temperatures, therefore highlighting a possible interaction between TH depth and serum potassium abnormality. This has clear clinical implications with regards to the depth of TH.
DISCUSSION
Influence on neurological outcome
This review suggests that TH may improve neurological outcome in patients with TBI; however, the results from the studies are varied with contradictions regarding its efficacy. The studies are of variable quality, with little explanation of randomization methods and allocation concealment affecting the reliability and validity of results, whilst the small samples sizes means that findings cannot be confidently generalized to the wider population (Parahoo, 2014) . Perhaps the highest quality study in this review, Clifton et al. (2011) , concluded that TH is not effective at improving neurological outcome and has no basis for further research. Nevertheless, there are still undeniable trends that demonstrate that TH increases GOS scores and reduces mortality rates. With regards to neurological outcome, the findings of this review are consistent with current systematic reviews and meta-analyses (McIntyre et al., 2003; Alderson et al., 2004; Peterson et al., 2008; Pengcheng and Chaohua, 2014) , which all identify a trend towards a positive influence on neurological outcome and acknowledge that there is a lack of uniformity with regards to TH protocols among the studies.
Within the studies, there are variations relating to methods of inducing TH, target temperature, duration of cooling and rate of re-warming, all of which are key factors known to influence neurological outcome (Finkelstein and Alam, 2010) . It is accepted that TH must be induced as early as possible in order to be of benefit (Clifton et al., 2001 (Clifton et al., , 2011 Bersten et al., 2014) . Neuronal death is known to occur within hours following primary brain injury compared to several days for secondary brain injury as a result of ischaemic damage (Berger et al., 2006) . It is therefore interesting that Clifton et al. (2011) , a study which reported the most rigorous protocols for early induction, did not find a positive relationship between TH and neurological outcome. The efficacy of early-induced TH can be considered in relation to the pathogenesis of TBI. Bersten et al. (2014) outline three phases of TBI and changes in CBF and ICP spanning 2 weeks post-injury. TH would influence the first two phases:
1. The first 72 h (hypoperfusion phase) after initial injury marks a decrease in CBF and resultant global/regional ischaemia because of impaired autoregulation, which requires an adequate systemic blood pressure in order to maintain CPP. 2. This is followed by the hyperaemic phase during which autoregulation mechanisms may start to recover in some patients, resulting in improved CBF. However, any hyperaemia combined with intracranial inflammation and compromised BBB permeability can result in vasogenic cerebral oedema, and therefore, therapies that aim to maintain CBF may potentiate the occurrence of IH (Bersten et al., 2014) .
In this context, TH may be more effective 72 h post-injury when CBF is more controlled, especially as TH is associated with hypotension and may further compromise CBF during the initial hypoperfusion stage (Polderman, 2008) . This correlation has not previously been considered in other reviews.
Duration of cooling is also considered to influence neurological outcome (McIntyre et al., 2003) . Jiang et al. (2006) observed that patients who were cooled for 5 days had significantly better neurological outcomes compared to patients cooled for 2 days. Two meta-analyses found that only TH maintained for longer than 48 h was associated with a lower mortality rate and improved neurological outcome (McIntyre et al., 2003; Bratton et al., 2008) . The optimal duration of TH is unknown; however, this review suggests that TH is more effective when instituted for longer than 48 h. The ability to cope with an increased ICP differs from person to person (McLeod, 2004) , therefore requiring individualized management and reassessment of re-warming rates depending on initial responses of ICP, which has nursing implications. It is therefore unsurprising that Lee et al. (2010) was successful in improving neurological outcome by re-warming patients only when the ICP returned to acceptable levels and cooling for a further 48 h if there was indication that ICP was rebounding; this is, however, a small study involving one centre. A previous study adopted a similar protocol with positive results by slowing or stopping re-warming when ICP began to increase, noting an average duration of 4⋅8 days and even up to 21 days in some patients (Polderman et al., 2002) . However, this recommendation is not within current clinical guidelines and should be considered by clinicians.
Influence on ICP
All studies, with the exception of Clifton et al. (2011) , found that TH was effective at reducing ICP. Clifton et al.'s (2011) findings were unique in that the TH group had a higher incidence of IH compared to the normothermia group; however, lower doses of morphine and higher doses of vasopressors were used to reduce TH-induced hypotension as observed in their previous study (Clifton et al., 2001) . Most studies used surgical decompression and external ventricular drainage when ICP could not be controlled. It is therefore difficult to ascertain whether TH or other interventions influenced decreases in ICP.
This review has, however, identified a link between the duration of cooling and the occurrence of rebound IH. Jiang et al. (2006) found that ICP was more likely to rebound during re-warming when TH was maintained for 48 h. This may be because of exacerbation of the hyperaemia phase by early re-warming causing a subsequent increase in CBF, which may then cause ICP to rebound (Bersten et al., 2014) . It is also acknowledged that reduced ICP does not necessarily correlate to improved neurological outcome (Stocchetti et al., 2015) as TH is also considered to improve outcome through prevention of neuronal death and attenuation of various chemical cascades (Polderman, 2004) .
Correlation between neurological outcome and brain pathology
There is a trend of improved neurological outcome in patients with haematoma-type lesions compared to patients with diffuse brain injury and contusions. This is supported by previous studies, which also reported that the effectiveness of TH in patients with extra-cerebral haematomas correlated to the degree of midline shift, whereas patients with focal cerebral lesions were found to benefit the most from TH (Shiozaki et al., 1998 (Shiozaki et al., , 2003 .
Complications
Fewer complications and an improved mortality rate were associated with TH at 35 ∘ C compared to cooling at 33 ∘ C (Tokutomi et al., 2009) , which has implications with regards to the recommended depth of TH. It is known that lower temperatures increase the likelihood of severe complications such as severe ventricular arrhythmias and hypokalaemia (Clifton et al., 1992 (Clifton et al., , 1993 Wright, 2005) . Hypokalaemia was documented in studies cooling patients to 33 ∘ C, suggesting a link to lower temperature management (Tokutomi et al., 2009; Clifton et al., 2011) . Additionally, two studies noted higher incidence of thrombocytopenia in the TH groups (Qiu et al., 2005; Qiu et al., 2007) , whilst Clifton et al. (2011) reported a slight but significant increase in PTT, indicating an increased risk of bleeding. Coagulopathies are known complications of TH; however, the incidence is variable (Finkelstein and Alam, 2010) . Interestingly, none of the studies addressed the effects of TH on glycaemic control, despite its importance in head-injured patients (Bersten et al., 2014) . TH is known to cause insulin resistance and decreased production causing, hyperglycaemia (Polderman, 2004) . Glucose control is an area requiring further research in the context of TH and TBI.
Limitations
The main limitation of this review is the distinct variation in protocols between the eight studies, making comparison difficult and findings less generalizable. There are gaps in data reporting, predominately relating to the time taken to induce TH and re-warming rates, leading to insufficient data to fully analyse the effects of TH. Aside from the differences in TH management, variations exist in the use of co-interventions such as surgical decompression and ventricular drainage as well as inclusion/exclusion criteria between the studies, making it difficult to conclude whether any positive effects are because of TH, co-interventions or differences in sample demographics or disease severity. Six of the eight studies were conducted in Asia, so consideration of transferability of results to other health care systems is required.
IMPLICATIONS AND RECOMMENDATIONS FOR PRACTICE
Clinically, it is difficult to confidently recommend the use of TH because of the variable quality of studies and differences between management protocols and patient characteristics. However, the need for individualized TH management has been highlighted. The ability to cope with increased ICP differs between patients and is influenced by the protocols of TH induction, duration and time of re-warming. Of particular note is the role of autoregulation and the influence temperature management has on cerebral haemodynamics. In short, the key messages from this review are that patients need to be cooled soon enough, long enough and re-warmed slowly depending on ICP responses in order to effectively improve neurological outcome and reduce the risk of complications. Current clinical guidelines do not make these recommendations explicit.
Further prospective multi-centred RCTs are needed to fully investigate the beneficial effects of TH. This review has highlighted areas for further research: titrating target temperatures in line with cerebral haemodynamic changes known to occur with TBI and further investigation of the efficacy of TH depending on the type of brain injury. Additionally, multi-centred RCTs would reduce inter-centre variance of TH management and ensure that the research protocols are consistent, therefore enabling accurate analysis of results.
Conclusion
Despite the lack of high-quality research, this review shows that TH may improve neurological outcome in patients with TBI, with low risk of severe complications. This review suggests that patients with contusions demonstrate little or no benefit from receiving TH in place of normothermia treatment. It also suggests that a longer duration of cooling may be beneficial, and continuation of cooling should be considered by the clinical teams if rebound IH occurs.
WHAT IS KNOWN ABOUT THIS TOPIC
• Research has shown variable effectiveness of TH following traumatic head injury in improving patient outcome.
• TH does not necessarily have a sustained effect on controlling ICP.
WHAT THIS PAPER ADDS
• There needs to be an individualized approach to TH, especially if rebound intracerebral hypertension is observed during re-warming.
• Therapeutic hypothermic should not be limited to 48 h, and if rebound intracerebral hypertension is observed, there is some evidence to suggest that recommencing TH may be of help.
• With regards to the timing and extent of TH, underlying alterations in cerebral haemodynamics should be taken into consideration.
• TH may be more effective in improving patient outcome when haematomas have developed as opposed to patients with cerebral contusions and/or diffuse injuries.
